Clinical trial for AstraZeneca/Oxford Covid-19 vaccine has resumed in US: company
The clinical trial for the COVID-19 vaccine being developed by AstraZeneca and Britain's University of Oxford has resumed in the United States, the drugmaker said Friday.
"The Food and Drug Administration (FDA) today authorised the restart in the US, following the resumption of trials in other countries in recent weeks," AstraZeneca said in a statement.
The US was the only country where the trial remained suspended following a participant's illness six weeks ago.
© 2020 AFP
Citation:
Clinical trial for AstraZeneca/Oxford Covid-19 vaccine has resumed in US: company (2020, October 23)
retrieved 19 April 2024
from https://medicalxpress.com/news/2020-10-clinical-trial-astrazenecaoxford-covid-vaccine.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
